儿童青少年精神分裂症的药物治疗ppt课件

1、.,1,儿童青少年精神分裂症的药物治疗,.,2,参 考 文 献,中华医学会精神病学分会. 精神分裂症防治指南（第二版）.2015.(140). 精神病学（第五版） American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):976-90. Howes

2、OD, et al. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. Am J Psychiatry. 2016 Dec 6:appiajp201616050503. Hiemke C, Baumann P, Bergemann N,等. AGNP精神科治疗药物监测共识指南:2011J. 实用药物与临床, 2016, 19(10). C

3、orrell C U, Manu P, Olshanskiy V, et al. Cardiometabolic Risk of Second-Generation Antipsychotics During First-Time Use in Children and AdolescentsJ. Jama the Journal of the American Medical Association, 2009, 302(16):1765-1773.,.,3,定 义,儿童青少年精神分裂：起病年龄18岁的一种病因未明，临床上以基本个性改变、特征性思维障碍、感知觉异常、情感与环境不协调、孤独性表

4、现为主要特征的精神障碍。 儿童青少年精神分裂症分为： 起病年龄1318岁的早发性精神分裂症 起病年龄13岁的儿童期发病的精神分裂。 儿童青少年精神分裂症的诊断，与成人相同，不考虑发病年龄。,American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):9

5、76-90.,.,4,儿童青少年期抗精神病药物使用现状,中华医学会精神病学分会. 精神分裂症防治指南（第二版）.2015.(140). American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):976-90.,.,5,选 药 原 则,中华医学会精神病

6、学分会. 精神分裂症防治指南（第二版）.2015.(140). American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):976-90.,.,6,2016年12月6日AJP发表的难治性精神分裂症标准,Howes OD, et al. Treatmen

7、t-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. Am J Psychiatry. 2016 Dec 6:appiajp201616050503.,.,7,相 互 作 用,Hiemke C, Baumann P, Bergemann N,等. AGNP精神科治疗药物监测共识指南:2011J. 实用药物与临床, 2016, 19(10).,.,8,药 物

8、不 良 反 应,中华医学会精神病学分会. 精神分裂症防治指南（第二版）.2015.(140). American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):976-90.,.,9,代 谢 紊 乱,Correll C U, Manu P, Olshans

9、kiy V, et al. Cardiometabolic Risk of Second-Generation Antipsychotics During First-Time Use in Children and AdolescentsJ. Jama the Journal of the American Medical Association, 2009, 302(16):1765-1773.,.,10,代 谢 紊 乱,Correll C U, Manu P, Olshanskiy V, et al. Cardiometabolic Risk of Second-Generation A

10、ntipsychotics During First-Time Use in Children and AdolescentsJ. Jama the Journal of the American Medical Association, 2009, 302(16):1765-1773.,.,11,代 谢 紊 乱,American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schi

11、zophrenia. J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):976-90.,.,12,EPS 副作用,中华医学会精神病学分会. 精神分裂症防治指南（第二版）.2015.(140). American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc

12、Psychiatry. 2013 Sep;52(9):976-90.,.,13,其 他 ADR,中华医学会精神病学分会. 精神分裂症防治指南（第二版）.2015.(140). American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):976-90.,.